Dear Editor,Premacular hemorrhage is a common cause of sudden profound visual loss in otherwise healthy eye.One of the commonest causes of premacular hemorrhage in clinical practice is Valsalva retinopathy,which was f...Dear Editor,Premacular hemorrhage is a common cause of sudden profound visual loss in otherwise healthy eye.One of the commonest causes of premacular hemorrhage in clinical practice is Valsalva retinopathy,which was first described by Thomas Duane in 1972[1].展开更多
Valsalva retinopathy was described as a particular form of retinopathy, pre-retinal and subinternal limiting membrane haemorrhages in nature that rarely may break through and become subhyloid or intravitreal, secondar...Valsalva retinopathy was described as a particular form of retinopathy, pre-retinal and subinternal limiting membrane haemorrhages in nature that rarely may break through and become subhyloid or intravitreal, secondary to a sudden increase in intrathoracic pressure. We reported a new way that Nd:YAG laser for ILM hyaloidotomy in order to drain the sub-ILM blood into vitreous cavity combined with intravitreal bevacizumab to improve the absorption of blood. Therapeutic alliance make significant outcome, protecting vision in time. We used spectralis OCT to observe sub-ILM mix cells and special ILM structure in this lesion for the first time, as the spectralis OCT can reach histology level imagination.展开更多
文摘Dear Editor,Premacular hemorrhage is a common cause of sudden profound visual loss in otherwise healthy eye.One of the commonest causes of premacular hemorrhage in clinical practice is Valsalva retinopathy,which was first described by Thomas Duane in 1972[1].
文摘Valsalva retinopathy was described as a particular form of retinopathy, pre-retinal and subinternal limiting membrane haemorrhages in nature that rarely may break through and become subhyloid or intravitreal, secondary to a sudden increase in intrathoracic pressure. We reported a new way that Nd:YAG laser for ILM hyaloidotomy in order to drain the sub-ILM blood into vitreous cavity combined with intravitreal bevacizumab to improve the absorption of blood. Therapeutic alliance make significant outcome, protecting vision in time. We used spectralis OCT to observe sub-ILM mix cells and special ILM structure in this lesion for the first time, as the spectralis OCT can reach histology level imagination.
